[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP1461332A4 - Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids - Google Patents

Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids

Info

Publication number
EP1461332A4
EP1461332A4 EP02786817A EP02786817A EP1461332A4 EP 1461332 A4 EP1461332 A4 EP 1461332A4 EP 02786817 A EP02786817 A EP 02786817A EP 02786817 A EP02786817 A EP 02786817A EP 1461332 A4 EP1461332 A4 EP 1461332A4
Authority
EP
European Patent Office
Prior art keywords
amino acids
alpha
production
sulfonyl
chirally pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02786817A
Other languages
German (de)
French (fr)
Other versions
EP1461332A2 (en
Inventor
Lynn Resnick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46204648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1461332(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US10/014,304 external-priority patent/US6610734B2/en
Priority claimed from US10/166,896 external-priority patent/US6657070B2/en
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of EP1461332A2 publication Critical patent/EP1461332A2/en
Publication of EP1461332A4 publication Critical patent/EP1461332A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP02786817A 2001-12-11 2002-11-26 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids Withdrawn EP1461332A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14304 1998-01-27
US10/014,304 US6610734B2 (en) 2000-12-13 2001-12-11 Heterocyclic sulfonamide inhibitors of beta amyloid production
US166896 2002-06-11
US10/166,896 US6657070B2 (en) 2000-12-13 2002-06-11 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
PCT/US2002/038117 WO2003050062A2 (en) 2001-12-11 2002-11-26 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS

Publications (2)

Publication Number Publication Date
EP1461332A2 EP1461332A2 (en) 2004-09-29
EP1461332A4 true EP1461332A4 (en) 2009-10-21

Family

ID=46204648

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02786817A Withdrawn EP1461332A4 (en) 2001-12-11 2002-11-26 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids

Country Status (7)

Country Link
EP (1) EP1461332A4 (en)
JP (1) JP4615861B2 (en)
AU (2) AU2002351170B8 (en)
CA (1) CA2470111A1 (en)
MX (1) MXPA04005366A (en)
TW (1) TWI260316B (en)
WO (1) WO2003050062A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002245123B2 (en) 2000-12-13 2007-05-24 Arqule, Inc. Heterocyclic sulfonamide inhibitors of beta amyloid production
JP2006522126A (en) 2003-03-31 2006-09-28 ワイス Fluoro-containing and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors and their derivatives for β-amyloid production
WO2005073198A1 (en) 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
CN101472877A (en) 2006-04-21 2009-07-01 惠氏公司 Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326934A1 (en) * 1988-02-02 1989-08-09 BASF Aktiengesellschaft Process for the reduction of reducible compounds
WO2001009084A1 (en) * 1999-08-03 2001-02-08 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264577A (en) * 1992-04-22 1993-11-23 Warner-Lambert Company Cyclic amino acids and derivatives thereof
ATE172717T1 (en) * 1992-08-25 1998-11-15 Searle & Co HYDROXYETHYLAMINOSULFONAMIDES USABLE AS INHIBITORS OF RETROVIRAL PROTEASES
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326934A1 (en) * 1988-02-02 1989-08-09 BASF Aktiengesellschaft Process for the reduction of reducible compounds
WO2001009084A1 (en) * 1999-08-03 2001-02-08 Eastman Chemical Company Process for the preparation of cyclopropylglycine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J.C. SPEELMAN ET AL, J. ORG. CHEM., vol. 54, no. 5, 1989, pages 1055 - 1062, XP002542789 *
T. INABA ET AL, J. ORG. CHEM., vol. 56, no. 3, 1991, pages 1274 - 1279, XP002542836 *

Also Published As

Publication number Publication date
TW200306292A (en) 2003-11-16
AU2002351170B2 (en) 2009-09-24
AU2002351170A1 (en) 2003-06-23
TWI260316B (en) 2006-08-21
JP4615861B2 (en) 2011-01-19
EP1461332A2 (en) 2004-09-29
WO2003050062A3 (en) 2003-11-20
CA2470111A1 (en) 2003-06-19
WO2003050062A2 (en) 2003-06-19
AU2009251195A1 (en) 2010-01-21
JP2005511727A (en) 2005-04-28
MXPA04005366A (en) 2004-09-27
AU2002351170B8 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
EP1404851A4 (en) Production of proteins in plants
IL157562A0 (en) NEW ELONGASE GENE AND PRODUCTION OF Delta9-POLYUNSATURATED FATTY ACIDS
IL158328A0 (en) Surface proteins of streptococcus pyogenes
EP1390470A4 (en) Production of alpha-lipoic acid
HK1067361A1 (en) Direct production of high purity fischer-tropsch wax
EP1383735A4 (en) Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
IL157426A0 (en) Peg-conjugates of hgf-nk4
IL161490A0 (en) Racemic tamsulosin free base and methods of making the same
EP1359861A4 (en) Pin-retained inlay bridge and process of making and fitting such
IL162206A0 (en) Production of chirally pure-aminoacid and n-sulfo nyl amino acids
GB2387597B (en) Stereoselective preparation of 3-hydroxy-3-phenylpropionitrile
GB2401094B (en) Labels and methods of manufacture thereof
EP1461332A4 (en) Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids
GB2374097B (en) Decoration of conservatories
IL161741A0 (en) Methods of reversing and preventingcardiovascular pathologies
IL147734A0 (en) Thermistor and method of manufacture
GB2375353B (en) Production and use of methanol and bi-product
DE60209229D1 (en) MULTICOLORED PICTURE PRODUCT AND THIS USE OF MULTICOLORED PICTURE PRODUCTION METHOD
EP1288215B8 (en) Production method of famciclovir and production and crystallization method of intermediate therefor
HK1056745A1 (en) Transgulatminase gene of streptovertcillium ladakanum and the transglutaminase encoded therefrom
GB2413134B (en) Decoration of conservatories
GB0225476D0 (en) Labelled proteins and production and uses thereof
GB0108212D0 (en) Methods of protein purification and uses thereof
GB0108214D0 (en) Methods of protein purification and uses thereof
GB0212113D0 (en) Manufacture of signs

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040609

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1066220

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20090923

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 215/08 20060101ALI20090915BHEP

Ipc: C07C 213/00 20060101ALI20090915BHEP

Ipc: C07C 229/08 20060101ALI20090915BHEP

Ipc: C07C 227/26 20060101ALI20090915BHEP

Ipc: C07C 227/32 20060101ALI20090915BHEP

Ipc: C07D 333/34 20060101AFI20090915BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: WYETH LLC

17Q First examination report despatched

Effective date: 20101026

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110308

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1066220

Country of ref document: HK